Discovery of dually acting small-molecule inhibitors of cancer-resistance relevant receptor tyrosine kinases EGFR and IGF-1R. Medicinal Chemistry Communications, 2016 by Andrew Khouri | Nov 20, 2023
N-Acetyl-3-aminopyrazoles block the noncanonical NF-kB cascade by selectively inhibiting NIK. Medicinal Chemistry Communications, 2018 by Andrew Khouri | Nov 20, 2023
Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3β. Medicinal Chemistry, 2014 by Andrew Khouri | Nov 20, 2023